The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 4, 2009, Pages 410.e1-410.e5

  Durnwald, Celeste P ^a   Lynch, Courtney D ^a,b   Walker, Hetty ^a   Iams, Jay D ^a  

^a BAYLOR UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

17 OHPC; cervical length; preterm birth; progesterone

Indexed keywords

17 ALPHA HYDROXYPROGESTERONE CAPROATE; PROGESTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CERVICAL LENGTH MEASUREMENT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HUMAN; MEDICAL RECORD REVIEW; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRANSVAGINAL ECHOGRAPHY;

EID: 70349306247     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.07.009     Document Type: Article

References (22)

1. Iams J.D., Goldenberg R.L., Meis P.J., et al. The length of the cervix and the risk of spontaneous premature delivery: the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. N Engl J Med 334 (1996) 567-572
2. Berghella V., Tolosa J.E., Kuhlman K., Weiner S., Bolognese R.J., and Wapner R.J. Cervical ultrasonography compared with manual examination as a predictor of preterm delivery. Am J Obstet Gynecol 177 (1997) 723-730
3. Berghella V., Daly S.F., Tolosa J.E., et al. Prediction of preterm delivery with transvaginal ultrasonography of the cervix in patients with high risk pregnancies: does cerclage prevent prematurity?. Am J Obstet Gynecol 181 (1999) 809-815
4. Guzman E.R., Walters C., Ananth C.V., et al. A comparison of sonographic parameters in predicting spontaneous preterm birth in high risk singleton gestations. Ultrasound Obstet Gynecol 18 (2001) 204-210
5. Iams J.D., Johnson F.F., Sonek J., Sachs L., Gebauer C., and Samuels P. Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol 172 (1995) 1097-1106
6. Andrews W.W., Copper R., Hauth J.C., Goldenberg R.L., Neely C., and Dubard M. Second trimester cervical ultrasound: associations with increased risk for recurrent early spontaneous delivery. Obstet Gynecol 95 (2000) 222-226
7. Owen J., Yost N., Berghella V., Thom E., Swain M., and Dildy G. Midtrimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 286 (2001) 1340-1348
8. Durnwald D.P., Walker H., Lundy J.C., and Iams J.D. Rates of recurrent preterm birth by obstetrical history and cervical length. Am J Obstet Gynecol 193 (2005) 1170-1174
9. Creasy R.K., Gummer B.A., and Liggins G.C. System for predicting spontaneous preterm birth. Obstet Gynecol 55 (1980) 692-695
10. Savitz D.A., Blackmore C.A., and Thorp J.M. Epidemiologic characteristics of preterm delivery: etiologic heterogeneity. Am J Obstet Gynecol 164 (1991) 467-471
11. Goldenberg R.L., Mayberry S.K., Copper R.L., Dubard M.B., and Hauth J.C. Pregnancy outcome following a second trimester loss. Obstet Gynecol 81 (1993) 444-446
12. Mercer B.M., Goldenberg R.L., Moawad A.H., et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome: the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Am J Obstet Gynecol 181 (1999) 1216-1221
13. Hoffman H.J., and Bakketeig L.S. Risk factors associated with the occurrence of preterm birth. Clin Obstet Gynecol 27 (1984) 539-552
14. Carr-Hill R.A., and Hall M.H. The repetition of spontaneous preterm labour. BJOG 92 (1985) 921-928
15. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate: the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. N Engl J Med 348 (2003) 2379-2385
16. da Fonseca E.B., Bittar R.E., Carvalho M.H.B., and Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188 (2003) 419-424
17. da Fonseca E.B., Celik E., Parra M., Singh M., and Nicolaides K.H. Progesterone and the risk of preterm birth among women with a short cervix: the Fetal Medicine Foundation Second Trimester Screening Group. N Engl J Med 357 (2007) 462-469
18. Facchinetti F., Paganelli S., Comitini G., Dante G., and Volpe A. Cervical length changes during preterm cervical ripening: effects of 17 alpha hydroxyprogesterone caproate. Am J Obstet Gynecol 453 (2007) e1-e4
19. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: National Institutes of Health Publication no. 98-4083 (1998), National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD
20. Spong C.Y., Meis P.J., Thom E.A., et al. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery. Am J Obstet Gynecol 193 (2005) 1127-1131
21. Bakketeig L.S., and Hoffman H.J. Epidemiology of preterm birth: results from a longitudinal study of births in Norway. In: Elder M.G., and Hendricks C.H. (Eds). Preterm labor (1981), Butterworths, London 17
22. Mercer B.M., Goldenberg R.L., Das A., et al. The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol 174 (1996) 1885-1895